株式会社マルタケ
Niigata, Japan
Active| Registration number | T3110001005348 |
|---|---|
| Type | Corporation |
| Registered name | 株式会社マルタケ |
| Address | 新潟県新潟市西区流通センター４丁目６番地２ 4-6-2 Ryutsusenta, Niigata-shi Kita-ku, Niigata 950-2031, JAPAN |
| Corporate number | 3110001005348 |
| Corporate number assigned on | 2015-10-05 |
| Invoice registered on | 2023-10-01 |
Invoice registration date = when the T-number took effect, not the founding date.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Representative | 代表取締役 茂木 稔之 |
| Reading (furigana) | マルタケ |
| Reading (romaji) | Marutake |
| English name (unofficial) | Marutake |
| Postal code | 950-2031 |
Source: NTA Corporate Number Publication Site, refreshed daily. Representative: gBizINFO (METI, monthly).
Company profile (gBizINFO)
| Business summary | 医療用医薬品、医療機器、医療用検査試薬、介護用品、健康食品、一般用医薬品等の卸売業 |
|---|---|
| Business lines | I:卸売業、小売業 |
| Employees | 489 |
| Incorporated | 1950-02-25 |
Source: gBizINFO (METI), refreshed monthly — edited extract by LoreaTec. Figures are as filed by each company.
Government contract awards (GEPS)
1 national government awards on record between 2022-10-21 and 2022-10-21.
| 2022-10-21 | 新型コロナウイルス抗原測定キット |
|---|
Full award history on Japan Tenders →
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥9.7M).
| 2025 FY2024 | 多国間・２国間交流 ¥9.7M （防衛省） 医薬品等の取得に係る業務を担う |
|---|
Contract details (excerpt): ロキソプロフェン錠６０ｍｇ「ＥＭＥＣ」 ¥6.4M・一般競争契約（最低価格） · bidders 3 ／ ＳＰトローチ０．２５ｍｇ「明治」 ¥3.4M・一般競争契約（最低価格） · bidders 4
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t3110001005348) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-25.
Reuse and AI use allowed with attribution. AI content licence